An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)

NCT00960362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: AGS-009
DRUG: placebo

Sponsor

Argos Therapeutics